Tango Therapeutics, Inc. (TNGX) Insider Trading -- Recent Executive & Director Transactions
15 insiders reported 72 Form 4 transactions for Tango Therapeutics, Inc. (TNGX) over the past 18 months (most recent 2026-10-05). Recent activity: Crystal Adam (President, R&D) Sell 26,400 shares, Crystal Adam (President, R&D) Buy 27,000 shares, Crystal Adam (President, R&D) Sell 600 shares, Newcomb Jessica (Principal Accounting Officer) Sell 700 shares, Newcomb Jessica (Principal Accounting Officer) Sell 5,100 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Crystal Adam | President, R&D | Sell | 26,400 | $645,604 |
| 2026-10-05 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-10-05 | Crystal Adam | President, R&D | Sell | 600 | $15,192 |
| 2026-09-24 | Newcomb Jessica | Principal Accounting Officer | Sell | 700 | $15,962 |
| 2026-09-24 | Newcomb Jessica | Principal Accounting Officer | Sell | 5,100 | $122,238 |
| 2026-09-24 | Newcomb Jessica | Principal Accounting Officer | Sell | 2,400 | $60,412 |
| 2026-09-03 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-09-03 | Crystal Adam | President, R&D | Sell | 27,000 | $603,909 |
| 2026-08-05 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-08-05 | Crystal Adam | President, R&D | Sell | 5,267 | $141,100 |
| 2026-08-05 | Crystal Adam | President, R&D | Sell | 21,733 | $594,417 |
| 2026-07-02 | Crystal Adam | President, R&D | Sell | 19,629 | $575,962 |
| 2026-07-02 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-07-02 | Crystal Adam | President, R&D | Sell | 7,371 | $222,946 |
| 2026-06-23 | Azelby Robert | Director | Buy | 5,740 | $0 |
| 2026-06-08 | Ketchum John B | Director | Buy | 4,000 | $0 |
| 2026-06-08 | Lee Sung | Director | Buy | 570 | $0 |
| 2026-06-08 | Rothenberg Mace | Director | Buy | 4,000 | $0 |
| 2026-06-08 | Calhoun Lesley Ann | Director | Buy | 4,000 | $0 |
| 2026-06-03 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-06-03 | Crystal Adam | President, R&D | Sell | 6,140 | $136,615 |
| 2026-06-03 | Crystal Adam | President, R&D | Sell | 20,860 | $481,032 |
| 2026-05-05 | Crystal Adam | President, R&D | Sell | 1,100 | $24,200 |
| 2026-05-05 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-05-05 | Crystal Adam | President, R&D | Sell | 25,900 | $548,821 |
Source: SEC Form 4 filings · as of 2026-10-05